Robert A Nissenson

Title: Innovations of Robert A. Nissenson in Osteoporosis Treatment

Introduction

Robert A. Nissenson is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of osteoporosis. His innovative work has led to the development of polypeptide analogs that have potential therapeutic applications.

Latest Patents

Nissenson holds 1 patent for his invention titled "Parathyroid hormone analogues useful for treatment of osteoporosis." This patent relates to polypeptide analogs that exhibit agonist or antagonist properties concerning parathyroid hormone (PTH), parathyroid hormone-like protein (PLP), or parathyroid-related protein (PTHrP). The invention focuses on substituting specific amino acids in the polypeptide chain to enhance pharmacological activity. These modified polypeptides are designed to treat various disease conditions, including cancer, osteoporosis, hypercalcemia, and hyperparathyroid disease.

Career Highlights

Nissenson's career is marked by his dedication to advancing medical science through innovative research. He is affiliated with the University of California, where he continues to explore the therapeutic potential of his inventions. His work has garnered attention for its implications in improving patient outcomes in osteoporosis treatment.

Collaborations

Nissenson has collaborated with esteemed colleagues, including Fred Ehrenkranz Cohen and Gordon J. Strewler. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his innovations.

Conclusion

Robert A. Nissenson's contributions to the field of osteoporosis treatment through his innovative polypeptide analogs demonstrate the importance of research and development in medicine. His work continues to pave the way for new therapeutic options for patients suffering from various conditions.